We are live on ! Find out more
ISEE

IVERIC bio

Delisted

ISEE was delisted on the 10th of July, 2023.

223 hedge funds and large institutions have $3.12B invested in IVERIC bio in 2022 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 61 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more capital inflows, than outflows

Capital inflows: $820M | Capital outflows: $350M

90% more funds holding in top 10

Funds holding in top 10: 10 → 19 (+9)

44% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 61

37% more call options, than puts

Call options by funds: $35.2M | Put options by funds: $25.6M

34% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 38

5% more funds holding

Funds holding: 213 → 223 (+10)

2.09% more ownership

Funds ownership: 106.49% → 108.58% (+2.1%)

Holders
223
Holders Change
+10
Holders Change %
+4.69%
% of All Funds
3.57%
Holding in Top 10
19
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+90%
% of All Funds
0.3%
New
51
Increased
88
Reduced
61
Closed
38
Calls
$35.2​M
Puts
$25.6​M
Net Calls
+$9.6​M
Net Calls Change
-⁠$105​M

ISEE Hedge Fund Activity: Q4 2022 in Review

223 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q4 2022, worth a combined $3.12B — up 38% from $2.26B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new ISEE positions and 38 closed out — a net gain of 13 holders — while 88 added to existing stakes and 61 trimmed.

The largest buyer was Vanguard Group, adding an estimated $86.1M. The largest seller was RTW Investments, cutting an estimated $59.8M.

  • 223 institutional investors held IVERIC bio (ISEE) as of Q4 2022, up from 213 in Q3 2022.
  • Funds reported $3.12B of IVERIC bio stock for Q4 2022, up 38% quarter-over-quarter.
  • 51 funds opened new IVERIC bio positions in Q4 2022 and 38 closed out, a net change of +13 holders.
  • The largest IVERIC bio buyer in Q4 2022 was Vanguard Group, an estimated $86.1M added.
  • The largest IVERIC bio seller in Q4 2022 was RTW Investments, an estimated $59.8M sold.

Based on aggregated 13F filings for Q4 2022.